Frequently asked questions
What are the different technologies developed by Genoskin?
Genoskin develops advanced human-based models that provide an ethical and scientifically robust alternative to animal testing. Generated from donated human skin tissue, our models maintain the natural architecture and immune cell repertoire of the skin:
- HypoSkin®, an ex vivo human skin model containing epidermis, dermis, and hypodermis, designed for studying subcutaneous and intradermal injections.
- NativeSkin®, a versatile epidermis-dermis model for topical and systemic studies. Variants include:
- Tape-Stripped NativeSkin® for skin barrier research
- WoundSkin® for wound healing, infection, and bacterial colonization
- HairSkin® derived from facial lift samples, with high follicle density
- FacialSkin derived from facial lift samples, with high sebaceous gland density
- InflammaSkin®, a T cell–driven, psoriasis-like model to test anti-psoriasis drugs (topical or injectable).
How do Genoskin's models have a similar structure to that of real human skin and show real human skin response?
Our skin models are derived from ethically donated human tissue from elective surgeries. Using a proprietary nourishing matrix, the tissue remains alive and functional for up to 7 days. Because these models preserve the full skin architecture, including keratinocytes, fibroblasts, adipocytes, melanocytes, and functional immune cells, they replicate authentic human skin structure and responses.
Discover HypoSkin® | Download HypoSkin Validation White Paper
Are Genoskin models immunocompetent?
Yes. Genoskin models contain 14 subtypes of functional immune cells that remain functional during the culture period. Our models have been shown to display immune responses when exposed to pro-inflammatory or immunotoxic compounds.
How does Genoskin preserve human skin viability? How long are the models viable?
We use a patented technology that mimics the skin’s natural environment:
- Surgical skin explants of controlled size are embedded in a solid gel matrix.
- A silicone ring preserves natural tension and biomechanical properties.
- Models are cultured in a chemically defined medium, which is replaced daily.
- The system maintains skin viability and functionality for up to 7 days.
How many models can you produce from a single donor?
The number of models depends on the type and size of the surgical sample:
- Abdominoplasty resections → up to 50 models per donor.
- Facial lift samples (used for HairSkin® or FacialSkin) → up to 15 models per donor.
How is donor-to-donor variability addressed in Genoskin models?
Donor variability is an inherent and valuable feature of our models, reflecting the diversity seen in real patient populations. All models are produced in a standardized manner, but we recommend testing with at least three donors to capture variability and ensure robust, statistically meaningful results.
What are the use cases of Genoskin’s ex vivo human skin models?
Our ex vivo models are versatile tools for many applications:
- HypoSkin®: Injection site reaction (ISR) studies, local tolerance, vaccine candidate screening, bolus injections, medical device testing, dermal filler characterization.
- NativeSkin®: Topical absorption, irritation and safety testing, claim substantiation, toxicity assessment, wound healing, skin microbiome research.
- InflammaSkin®: Evaluation of anti-psoriasis therapies delivered topically or subcutaneously.
What type of mast cells do you provide?
Genoskin offers Human Peripheral Blood-derived Mast Cells (PBCMCs), differentiated from CD34+ progenitor cells. These mast cells:
- Provide a reliable solution to help you study human primary mast cells’ response to your compound or formula
- Display reliable degranulation in response to anti-IgE stimulation
- Support studies on drug efficacy, safety, and immunotoxicity
What are the use cases of Genoskin’s human mast cells?
Our primary human mast cells can be applied to:
- Toxicity assessment: Monitor mast cell degranulation as an early marker of drug-induced toxicity.
- Allergic reactions: Assess a compound’s potential to trigger mast cell activation and allergic responses.
- Drug efficacy: Evaluate the efficacy of a drug candidate in inducing immune activation through mast cell degranulation.
Are your models suitable for both topical and injectable formulations?
Yes. Genoskin’s models are compatible with multiple administration routes:
- Topical applications
- Intradermal and subcutaneous injections
- Transdermal application, insertion and infusion
- Systemic administration
Can Genoskin’s skin models be used for long-term studies?
Our skin models remain alive and functional for up to 7 days, during which repeated treatments are possible. After this period, viability decreases and data variability increases, which is why we recommend studies within the 7-day culture window.
What assays and analyses can be performed on Genoskin’s skin models?
We offer a broad set of validated analyses through our service offerings, including:
- Viability assays (e.g., WST-8)
- Imaging: histology, immunofluorescence
- Multiplex cytokine profiling
- Transcriptomics: bulk and single-cell RNA sequencing
- Spatial biology using our proprietary MANTIS® platform
- Flow cytometry
This list is not exhaustive; we can adapt protocols and customize assays to meet your specific needs.
Contact us to discuss your project | Download validated NativeSkin® protocols
How do Genoskin’s models differ from animal models or reconstructed skin models?
- Compared to reconstructed skin: Our models preserve the full skin structure (epidermis, dermis, hypodermis), mature skin barrier, immune cells, and skin appendages (sweat glands, sebaceous glands, hair follicles). Genoskin models maintain the natural complexity and functionality of human skin, providing a more reliable platform for testing.
- Compared to animal models: Rodent and other animal skins differ in structure, barrier function, immune systems, and appendage distribution. Genoskin’s human skin models provide a directly translatable, human-relevant alternative for preclinical studies.
Do Genokin’s products allow standardized and reproducible experiments?
Yes. All our ex vivo human skin models are produced following strict, standardized protocols to ensure reproducibility. Because the models are made from real human skin, donor-to-donor variability is present, but this reflects true clinical variability and increases translational value.
Do you offer models from different anatomical sites (e.g., abdominal, breast, back)?
Yes. While most of our models come from abdominal skin resections, we also receive samples from arms, thighs, and facial lifts. Facial lift samples are used to create HairSkin® and FacialSkin® models. If your project requires tissue from a specific anatomical site, contact us, and we will do our best to accommodate your request.
Are your skin models available from donors of different ages or skin phototypes?
Yes. We collect skin from a diverse donor pool in France and the U.S. You can request custom models based on gender, age range, and phototype.
For reference:
- Most available donors are female (≈90%)
- Common age range: 30–50 years
- Most frequent phototypes: II–III
Requests for less common donor characteristics may extend the lead time.
Do skin models come in a standard size, or are there sizes to select from?
Yes, models are available in different diameters depending on the application:
- NativeSkin®: 8 mm, 11 mm, 20 mm
- Tape-Stripped NativeSkin® & WoundSkin®: 11 mm, 20 mm
- HairSkin® & FacialSkin®: 6 mm, 8 mm
- HypoSkin®: 20 mm
What if I need a model that is not one of the standard sizes that Genoskin produces?
We can produce custom sizes on a case-by-case basis. Please reach out to discuss your project needs
Do you have models from patients with specific conditions?
We only provide models from healthy donors.
Does Genoskin guarantee the safety of its products? Are models tested for infectious agents before shipment?
Yes. Every kit includes a batch release certificate confirming:
- Negative testing for HIV-1/2 and Hepatitis B & C
- H&E staining results
- Clinical donor information
Do I need specific authorizations to receive ex vivo human skin models?
No additional authorization is required on your end. Genoskin has all ethical requirements and regulatory compliance documentation in place for the use of skin models. Documentation can be provided if required by your institution.
How do you ensure the quality of your human mast cells? What quality assurance do you provide with each shipment?
Each batch of mast cells undergoes strict quality control before shipment, including:
- Flow cytometry for CD117 and FcεR1 marker expression
- Anti-IgE–mediated degranulation assays (CD63 surface expression & β-hexosaminidase release)
- Viability testing
QC data is delivered with each order.
Do you store the sampled skin? Will I receive freshly sampled tissue, or is it stored after surgery?
We do not store skin samples. Skin is shipped from the surgery sites immediately after surgery, delivered to our labs overnight, and models are produced the same day. The ready-to-use models are then shipped directly to customers.
What is the shelf life of the product? What is the recommended storage condition for the tissue?
Our skin models remain viable in culture for up to 7 days after production. We recommend starting your experiments immediately upon receipt.
- On delivery: add culture medium to the wells
- Place models in an incubator following the User Manual guidelines
Download the NativeSkin® User Manual | Download the HypoSkin® User Manual
Can I use the entire sample of your NativeSkin model after topical applications?
We recommend excluding the area covered by the silicone ring from analysis. Instead, use a sterile biopsy punch to collect skin from the exposed central area.
See detailed instructions in our User Manual
What type of equipment do I need in my lab when using the skin models or mast cells (e.g. biosafety cabinets, incubators)?
For skin model culture:
- Class II biological safety cabinet
- Incubator (37°C, 5% CO₂, 95% humidity)
- Water bath (37°C)
- Sterile micropipettors & pipette tips
For topical administration:
- Sterile forceps
- Positive displacement pipette (for semisolid materials)
- Mortar & pestle (for solid materials)
- Sharp spoon (for solid materials)
For subcutaneous/intradermal injections:
- 0.3 mL insulin syringe with 6–8 mm needle, 30G
- Sterile forceps
For mast cell culture:
- Class II biological safety cabinet
- Incubator (36–38°C, 4–6% CO₂, 95% humidity)
- Non-treated flasks or 6-well plates
Detailed instructions are provided in the User Manuals included with each kit.
Can Genoskin provide training for using the models for injections?
Yes. Genoskin provides hands-on and remote training options:
- In-person training: A Genoskin scientist can visit your lab, or your team can be trained at one of our facilities.
- Virtual consultations: Online sessions with a Genoskin scientist for tailored guidance and troubleshooting.
Both formats can be booked directly through our e-shop.
What kind of services does Genoskin provide?
Genoskin offers non-clinical contract research services that leverage human immunology to reduce risk in drug and product development by providing early access to reliable human data.
Our services cover:
- Drug Development
- Injection site reaction (ISR) assessment
- Local tolerance studies
- Human primary mast cell testing
- Vaccine development (VaxSkin®)
- Anti-psoriasis drug testing (InflammaSkin®)
- Cosmetics & Consumer Goods
- Claim substantiation
- Barrier function studies
- Topical delivery & safety evaluation
- Medical Devices
- Injection, dermal filler, and implant safety testing
What is the workflow to perform a service with Genoskin?
Our streamlined workflow ensures clarity and collaboration at every step:
- Introductory meeting: Virtual or in-person to discuss your project needs.
- Confidentiality agreement: A mutual CDA is signed to protect your data.
- Study plan: A Study Director drafts your plan while a Business Developer prepares a quote.
- Project initiation: Once approved and initiation payment is received, studies typically begin within 2 weeks.
- Execution & updates: Our team conducts the study and provides regular progress updates.
- Final deliverables: You receive a detailed report with results, conclusions, and recommendations. Raw data and study samples can also be provided upon request.
Where are the services performed?
All studies are performed in Genoskin’s BSL-2 laboratories located in:
- Toulouse, France
- Salem, Massachusetts, USA
The study location is chosen based on your location and the analyses required. Both facilities are staffed with technical experts and follow the same quality standards.
Can I get a personalized service offer for my study?
Yes. All Genoskin services are fully customizable. If your study does not fit within our packaged offers (ImmunoSafe®, VaxSkin®, cosmetic claim substantiation, psoriasis research, mast cells, etc.), our experts will design a tailored study plan to answer your specific scientific and development questions.
Do you provide protocol customization based on my study needs?
Yes. Our team can develop new protocols to match your research requirements. Feasibility is first evaluated with a Study Director, and if validated, we can provide a pilot study to establish the protocol.
Can you help design experiments for regulatory submissions?
Yes. Our Study Directors can design studies to meet regulatory expectations and deliver reports formatted for inclusion in IND applications or other submissions.
Can I send my own compounds for testing?
Yes. Customers typically send their own test articles and controls. Genoskin then manages the entire process, including model preparation, treatment, sampling, analysis, and data reporting.
What is the deliverable of Genoskin’s services?
Each service includes a comprehensive final report containing:
- Abstract
- Context & study objectives
- Materials & Methods
- Results (with figures/tables as relevant)
- Conclusions & recommendations
Optional:
- Intermediate reports (if agreed upon during study design)
- Raw data files provided upon request
Do you offer statistical analysis of results?
Yes. Statistical analysis is available to support interpretation and ensure robust, meaningful conclusions.
Can you perform comparative studies between multiple test articles?
Yes. We can design studies to compare multiple compounds or formulations, provided the total number of models does not exceed the maximum yield from a single skin sample (≈50 models).
How do you ensure confidentiality of my study and results?
Confidentiality is a top priority:
- A mutual CDA is signed at the start of collaboration.
- If third-party involvement is required, this is clearly defined in the study plan and subject to your approval.
- All study data and results are archived in Genoskin’s secure system and shared only with the customer.
Are there any specific steps or requirements for first-time buyers? How do I order?
Yes. First-time buyers must create an account before purchasing NativeSkin® or other models in our e-shop.
If you are based in the U.S. and belong to a tax-exempt organization, you’ll need to upload proof of tax exemption during sign-up. Our team will review your documentation and approve your account.
Once your account is approved, you can log in and place your order.
A representative will then collect your billing details. After this initial step, future orders will be faster and easier.
Can you ship your products everywhere? Can the products be shipped internationally while maintaining viability?
Yes. Genoskin ships globally. Our proprietary nourishing matrix and custom-designed insulated boxes protect models from temperature shifts and shocks during transport:
- Overnight delivery – U.S. and most European countries
- 72-hour delivery – Asia and other long-distance locations
This ensures that models remain viable and ready to use upon arrival.
Are there restrictions on purchasing human skin models in certain countries?
Our models are shipped as “Exempt Human Specimens” and require specific documentation for customs clearance. Genoskin provides all necessary paperwork in advance to simplify the import process.
⚠️ Please check your local regulations for importing human biological specimens.
Is the culture medium included in the price, or should it be purchased separately? How much medium is provided?
Yes. The culture medium is included with your model order. The quantity provided is sufficient to maintain the models in culture for up to 7 days.
If you need more, additional media can be purchased separately via our e-shop.
How long in advance should an order be placed?
Please place your order at least 2 weeks before your preferred delivery date to allow time for production planning and scheduling.
How long does it take before I receive my order?
When ordering, you can select a preferred week of delivery. Our production team makes every effort to meet your request. However, timing may shift depending on surgery schedules and sample quality.
Can I track my order once it’s shipped?
Yes. Once your order has shipped, you will receive an email with a tracking number, allowing you to follow the shipment in real time.
How are Genoskin products packed?
All products are shipped in shock-resistant, thermally insulated boxes designed for express airfreight. Packaging varies by product:
- Skin models (NativeSkin®, HypoSkin®, etc.): shipped at controlled temperature.
- HistoSkin and fresh hypodermis: shipped at room temperature.
- FrozenSkin: shipped with up to 10 kg of dry ice.
- Human mast cells: shipped at room temperature, with culture medium delivered refrigerated.
What happens if the models arrive damaged or non-viable?
We take every precaution to ensure safe delivery. However, if models arrive damaged or non-viable due to shipping issues, we will:
- Investigate the cause
- Provide a replacement production free of charge
For mast cells, please document the issue (photos + lot number) and contact support immediately. Our team will determine whether the issue stems from shipping, handling, or protocol deviations before providing a resolution.
Do you provide technical support after purchase?
Yes. Genoskin offers comprehensive technical support:
- Troubleshooting for issues such as contamination or necrosis
- Access to validated protocols on our website
- Optional training:
- In-person training for injections in HypoSkin® models (bookable via the e-shop)
- Virtual consultations (bookable via the e-shop)
For human primary mast cells, extended technical support is available—please contact us for assistance.
What payment methods do you accept?
We accept:
- Credit card payments at checkout
- Invoice-based payments (invoice issued upon delivery, 30-day payment terms)
Are bulk purchase discounts available?
Not typically. However, if you are planning large-volume or long-term orders, please discuss options with your local representative.
Do you offer subscription or standing order options for recurring studies?
Yes. We offer standing order options for customers running recurring studies. Contact our team to set up a plan tailored to your needs.
How does Genoskin obtain human skin tissue samples?
Genoskin partners with a network of hospitals and clinics in France and the U.S., operating under Biological Sample Transfer Contracts with each institution. These contracts ensure that all tissue sourcing complies with the highest ethical standards and applicable legal requirements.
Do you work with tissue banks or hospitals directly?
We work directly with hospitals and clinics to source skin tissue. This guarantees controlled logistics, regulatory compliance, and consistent sample quality.
Do all donors sign an informed consent form?
Yes. All donors sign an Informed Consent Form before undergoing elective surgical procedures such as abdominoplasties, arm lifts, or facelifts. Consent covers the use of donated skin tissue for scientific research and experiments, in line with the Declaration of Helsinki.
What are the typical donor characteristics (e.g., age, phototype, health status)?
To ensure both traceability and confidentiality, hospitals provide anonymized donor information, including:
- Age
- Gender
- Known skin conditions or diseases
- Current medications (e.g., corticosteroids, immunosuppressants, antibiotics)
Typical donor demographics:
- Gender: ~90% female
- Age: 30–50 years (≈60%)
- Phototype: II–III (≈90%)
That said, donors may be male or female, aged 18–90, and of any phototype.
Will I receive any donor information?
Yes. Each delivery includes a QA/QC lot release certificate with anonymized donor details:
- Age
- Gender
- Skin type/phototype
- Anatomical site of the tissue
From what types of surgeries are the skin samples sourced?
Most skin resections are obtained from:
- Abdominoplasties (≈60%)
- Circular abdominoplasties
- Thigh lifts
- Arm lifts
- Facelifts
- Eyelid surgery
How quickly after surgery are the skin samples processed?
Skin is processed into ex vivo models within 24 hours of surgery. In the meantime, tissue is kept at optimal temperature to preserve viability and integrity.
What is the traceability process for skin samples?
Each Biological Sample Transfer Contract mandates strict traceability:
- Rigorous hospital collection protocols
- Anonymized donor data (no identifying information is shared)
- Full documentation of sample handling from surgery to model production
What approvals and authorizations does Genoskin hold for skin sourcing?
Genoskin operates under full ethical and regulatory compliance, including:
- Informed donor consent for all cosmetic surgical procedures
- Donor approval aligned with the Declaration of Helsinki
- Authorization from the French Ministry of Research and Higher Education
- Oversight by Ethics Committees (CPP – Comité de Protection des Personnes)
- Legally binding Biological Sample Transfer Contracts with all partner hospitals and clinics
What ethical committees or institutional review boards (IRBs) oversee Genoskin’s work?
Genoskin’s work is conducted under the oversight of the CPP – Comité de Protection des Personnes (French Ethics Committee). We also hold official authorizations from the French Ministry of Research and Higher Education to ensure full compliance with ethical and legal requirements.
Does Genoskin follow international ethical guidelines (e.g., Declaration of Helsinki)?
Yes. Although Genoskin does not conduct in vivo clinical trials, we strictly follow the principles of the Declaration of Helsinki. This international declaration defines the ethical framework for research involving human subjects, including the use of human biological materials and identifiable data.
How does Genoskin balance scientific research needs with donor privacy and rights?
Donor rights and privacy are at the heart of our sourcing process:
- Informed consent: Every donor signs a consent form before undergoing elective surgery (e.g., abdominoplasty, brachioplasty, facelift). This form explains how their excised skin tissue may be used for research.
- Voluntary donation: Donors are free to decline donation without any impact on their surgery or treatment.
- Purpose transparency: Donors are informed that their tissue will contribute to the development of human skin models as alternatives to animal testing.
- Anonymization: All donor information is anonymized to ensure complete privacy.
In practice, most donors are pleased to contribute to advancing science by donating tissue that would otherwise be discarded.
How does using ex vivo human skin reduce reliance on animal models in research?
Genoskin’s models provide a scientifically robust alternative to animal testing. By using residual human skin tissue from surgery, our models are:
- Animal-component free (ACF) / Xeno-free (XF): No animal-derived materials are used.
- Designed to replace in vivo animal experiments for skin toxicity, irritation, safety, and efficacy testing.
- Able to bridge the gap between in vitro assays and human clinical trials by providing physiologically relevant human data.
This approach not only improves translational relevance but also actively reduces the need for animal testing in drug, vaccine, cosmetic, and medical device development.
In what ways are Genoskin’s solutions more ethical than animal testing?
Traditional animal testing raises significant ethical concerns and is increasingly restricted by regulators worldwide. The FDA is at the forefront of this trend with the Modernization Act 3.0, which authorized the use of certain alternatives to animal testing to support investigational use of a new drug. Genoskin provides a more ethical and scientifically relevant solution by:
- Using donated human skin tissue with informed consent, rather than live animals.
- Following strict international ethical regulations and donor privacy protections.
- Delivering human-relevant data that improves predictability and reduces reliance on animal experiments.
This ensures that product developers can advance research while respecting both human donor rights and animal welfare.
What certifications does Genoskin hold?
Genoskin has been ISO 9001:2015 certified since 2017 for its main facility in France. ISO 9001 is an internationally recognized quality management system (QMS) standard applicable to all industries. It is based on four key principles:
- Commitment and involvement of top management
- Strong customer focus
- A process-driven approach
- Continual improvement of systems and practices
How do you handle deviations or non-conformities in production?
All deviations and non-conformities are logged in our Quality Management System (QMS). Each case is reviewed by the team, and corrective and preventive actions (CAPA) are implemented to prevent recurrence.
If a deviation impacts a customer’s study or production, we will reproduce the affected models or repeat the impacted part of the study at no extra cost.
How does Genoskin ensure consistent quality across its models and services?
Consistency is achieved through:
- Standardized protocols and SOPs across Production, Services, and R&D
- Regular verification and updates of procedures
- Cross-team training to ensure uniform application of quality standards
This ensures that every model and study meets the same high level of scientific rigor and reproducibility.
Do you have internal or external audits?
Yes. Genoskin undergoes regular internal audits alongside external audits by AFNOR, an independent certification body.
- External audits are conducted annually
- All processes are reviewed: sourcing/biobanking, production, services, R&D, sales, quality, etc.
- Audits follow a 3-year certification cycle (1 initial audit + 2 follow-up audits)
This dual system guarantees compliance, transparency, and continuous improvement.
Can data generated with Genoskin’s solutions be used for both U.S. and EU regulatory filings?
Yes. Our Study Directors design studies that meet FDA, EMA, and other regulatory expectations. Reports are delivered in a format suitable for IND applications and additional regulatory submissions in both the U.S. and EU.
Are your models compliant with OECD testing guidelines?
Genoskin’s models are aligned with the principles of OECD testing guidelines. While our assays are not formally OECD-validated, our platforms are designed to support OECD-relevant endpoints such as skin irritation, absorption, penetration, and local toxicity.
How do Genoskin’s models fit within the FDA Modernization Act 3.0 recommendations?
The FDA Modernization Act 3.0 encourages the use of non-animal methods in preclinical testing. Genoskin’s ex vivo human skin models are:
- Validated, human-relevant alternatives to animal models
- Suitable for toxicity, safety, and efficacy studies of topicals, injectables, and medical devices
- Designed to improve human predictability and reduce species-specific discrepancies seen in animals
- Fully compatible with FDA guidelines for reproducibility, human relevance, and ethical standards
By adopting Genoskin’s models, pharma and biotech companies can accelerate their regulatory pathways, remain compliant with new U.S. regulations, and improve both scientific rigor and ethical practices.
How is pricing determined (per model, per batch, or per study)?
- Skin models: priced per model (depending on type and size)
- Human mast cells: priced per batch (1M, 2M, or 5M cells)
- Other products: pricing is clearly stated in our e-shop
- Studies: pricing is customized per study, based on:
- Number of models
- Treatments and readouts
- Data analysis and reporting
A Business Developer will provide a detailed quote for each study.
Do you provide quotes or cost estimates before starting a project?
Yes.
- Products: generate and download your own quote directly in our e-shop.
- Studies: after discussing your project, you’ll receive a study plan with a detailed quote. The study only begins once the quote is approved and a purchase order is received.
How much does a skin model cost?
Pricing depends on the model type and size. For reference, prices start at €/$99 per model.
Is there a minimum order quantity?
No. There is no minimum order requirement for models or studies.
Are shipping and handling costs included in the price?
No. Shipping and handling are charged separately:
- Packaging & handling: €/$100
- Shipping costs: depend on the destination region
What payment methods do you accept?
We accept:
- Credit card payments
- Invoice-based payments with 30-day terms
Do you offer academic or bulk order discounts?
- Products: our prices are already competitive, so no general discounts are offered.
- Services: discounts may be available on a case-by-case basis.
Can pricing be adapted for long-term partnerships or subscription models?
Yes. We are open to long-term pricing models or standing order subscriptions for recurring studies.
What are your invoicing and payment terms?
- Payment due within 30 days of invoice date
- No offsets or deductions unless agreed in writing
- For services:
- 50% initiation payment required
- Study begins after receipt of payment, customer materials, and a signed study plan
- Invoices follow the payment schedule agreed in the accepted quote
How does Genoskin work with customers on study design and execution?
- Kick-off meeting: You meet with a Study Director to define your needs.
- Study plan & quote: A tailored plan is drafted; a Business Developer prepares the quote.
- Review & adjust: The plan and quote can be refined to fit your goals.
- Project initiation: Study starts within 2 weeks of receiving:
- 50% initiation payment
- Your test articles
- Signed study plan
- Updates: Regular progress updates are shared.
- Final deliverables: A comprehensive report is delivered, with optional follow-up calls to discuss results and next steps.
Do I need to sign a non-disclosure agreement (NDA) before starting a project?
Yes, we recommend signing a mutual NDA at the start of any collaboration to protect confidentiality.
What is your cancellation or rescheduling policy for studies or orders?
- Orders cannot be canceled once a Purchase Order has been accepted.
- Modifications are possible but require confirmation from Genoskin.
- The confirmation will be communicated in writing and will include any changes (price, date, service scope) before being applied.
How can I contact the Genoskin team?
You can easily reach us by filling out the form on our Contact page. A member of our team will get back to you as quickly as possible.
What is the expected response time from your team?
We aim to respond to all inquiries within 48 hours during business days.
Do you have regional representatives or local distributors?
Yes. Genoskin has regional representatives for:
- EMEA-APAC
- UK
- North America – Northeast, West, and Mid-Atlantic
We also work with local distributors in Japan and India.
Do you provide scientific or technical support for using your models?
Yes. Genoskin offers comprehensive technical support:
- Troubleshooting: assistance for issues such as contamination or necrosis
- Validated protocols: available on our website
- Training options (bookable via our e-shop):
- In-person training for HypoSkin® injections
- Virtual consultations with our scientists
For human primary mast cells, extended technical support is available—please contact us for assistance.
Do you provide resources or documentation (e.g., protocols, user guides) with your models?
Yes. All models come with validated protocols, user manuals, and tutorials to guide your experiments. These resources are available in our Knowledge Hub.
Do you provide training on how to use your skin models?
Yes. Training is available in two formats:
- In-person training: one of our scientists can visit your lab, or your team can train at our facilities.
- Virtual consultations: remote sessions with a Genoskin scientist for tailored guidance.
Both options can be booked directly through our e-shop.
Do you offer post-study consultations or data interpretation support?
Yes. Once your study report is delivered, we systematically offer a follow-up call to:
- Review the results in detail
- Answer your scientific questions
- Discuss next steps or additional studies
Is customer support available in multiple languages?
Yes. Customer support is available in English and French.
Can I visit Genoskin’s facilities?
Yes. You are welcome to visit our facilities in:
- Toulouse, France
- Salem, Massachusetts, USA
Please contact us in advance to arrange your visit.
